Identification and Classification of Polymyalgia Rheumatica (PMR) and PMR-Like Syndromes Following Immune Checkpoint Inhibitors (ICIs) Therapy: Discussion Points and Grey Areas Emerging from a Systematic Review of Published Literature

Background: Polymyalgia Rheumatica (PMR) is one of the most frequent rheumatologic immune-related adverse effects (IRAEs) in cancer patients following therapy with immune checkpoint inhibitors (ICIs). Atypical findings in many patients often lead to diagnosing PMR-like syndromes. Materials and metho...

Descripción completa

Detalles Bibliográficos
Autores principales: Manzo, Ciro, Isetta, Marco, Natale, Maria, Castagna, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693468/
https://www.ncbi.nlm.nih.gov/pubmed/33153016
http://dx.doi.org/10.3390/medicines7110068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693468/
https://www.ncbi.nlm.nih.gov/pubmed/33153016
http://dx.doi.org/10.3390/medicines7110068

Ejemplares similares